Xintela Karin Wingstrand Interview

Xintela’s Board Member, Karin Wingstrand, has extensive Pharmaceutical Industry experience in leadership positions, for example, Global Vice President of Clinical Research and Development at AstraZeneca. She has worked with regulatory issues as well as the planning of large scale drug development. In the following video interview, Karin explains her role at Xintela and what she considers to be Xintela’s primary strengths.